Feasibility and Safety of Extended-Release Naltrexone Treatment of Opioid and Alcohol Use Disorder in HIV Clinics: A Pilot/Feasibility Randomized Trial

BACKGROUND AND AIMS: HIV-infected persons with substance use disorders are least likely to benefit from advances in HIV treatment. Integration of extended-release naltrexone (XR-NTX) into HIV clinics may increase engagement in the HIV care continuum by decreasing substance use. We aimed to compare 1...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Addiction
Asıl Yazarlar: KORTHUIS, P. Todd, LUM, Paula J., VERGARA-RODRIGUEZ, Pamela, AHAMAD, Keith, WOOD, Evan, KUNKEL, Lynn E., ODEN, Neal L., LINDBLAD, Robert, SORENSEN, James L., ARENAS, Virgilio, Doan, HA, MANDLER, Raul N., MCCARTY, Dennis
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5408318/
https://ncbi.nlm.nih.gov/pubmed/28061017
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/add.13753
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller